Mini Review
Published on 15 Sep 2025
Factors affecting response and resistance to venetoclax in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1577908
- 4,419 views
- 1 citation
Type at least 3 characters
2,001 articles
articles
Perspective
Published on 12 Sep 2025
Enhancing diagnostics through flow cytometry: overcoming barriers in low resource settings
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1604295
- 2,208 views
- 1 citation
Original Research
Published on 10 Sep 2025
Development of a novel prognostic model for mantle cell lymphoma based on quantitative detection of CD3 by quantitative dot blot
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1595572
- 1,722 views
Original Research
Published on 10 Sep 2025
Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1643160
- 1,601 views
Original Research
Published on 10 Sep 2025
A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1601782
- 2,041 views
Original Research
Published on 09 Sep 2025
Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1639819
- 1,524 views
Original Research
Published on 09 Sep 2025
Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1631511
- 1,590 views
Original Research
Published on 08 Sep 2025
Bone marrow involvement in solid tumors - a retrospective observational study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1434709
- 1,220 views
Case Report
Published on 08 Sep 2025
Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1639892
- 1,810 views
- 1 citation
Case Report
Published on 05 Sep 2025
Successful CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation in a secondary central nervous system lymphoma patient with COVID-19 infection: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1656034
- 1,790 views
Original Research
Published on 03 Sep 2025
IONPs combined with cytarabine downregulated IFITM3 expression to inhibit acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1515956
- 1,556 views
Case Report
Published on 03 Sep 2025
Case Report: Unraveling complex genomic alterations in a case of chronic lymphocytic leukemia using optical genome mapping
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1639849
- 2,146 views
Original Research
Published on 03 Sep 2025
Machine learning-based nomogram predicts heart failure risk in elderly relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1624680
- 1,713 views
Original Research
Published on 02 Sep 2025
Risk factors for thrombotic events in Philadelphia chromosome-negative myeloproliferative neoplasms: a retrospective analysis of 336 cases
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1639250
- 1,797 views
Clinical Trial
Published on 02 Sep 2025
Effectiveness and safety profile of chidamide as maintenance therapy for peripheral T-cell lymphoma: a multicenter real-world study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1596270
- 1,513 views
Original Research
Published on 29 Aug 2025
Real-world data on adult AML with FLT3-ITD mutation from the Thai acute leukemia working group
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1606943
- 2,323 views
Original Research
Published on 29 Aug 2025
A case report of TBL1XR1-RARB positive pediatric acute promyelocytic leukemia and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566404
- 1,656 views
Case Report
Published on 29 Aug 2025
Case Report: Transformation of natural killer-cell large granular lymphocytic leukemia to aggressive natural killer cell leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1648711
- 1,738 views
Brief Research Report
Published on 27 Aug 2025
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1645217
- 1,694 views
Brief Research Report
Published on 26 Aug 2025
Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1658257
- 1,950 views
Original Research
Published on 26 Aug 2025
Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1624761
- 2,098 views
- 1 citation
Case Report
Published on 25 Aug 2025
Successful remission induction therapy with azacitidine and venetoclax for a treatment-naive elderly patient with ETP/myeloid mixed-phenotype acute leukemia: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1628767
- 2,600 views
Systematic Review
Published on 22 Aug 2025
CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1641769
- 3,066 views
Case Report
Published on 20 Aug 2025
Extramedullary relapse of acute lymphoblastic leukemia treated with a CAR-T cell therapy bridge to unrelated cord blood transplantation: a case report and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1508676
- 2,477 views